CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 111 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,044 | -25.0% | 267,476 | 0.0% | 0.00% | – |
| Q2 2023 | $460,059 | +13.9% | 267,476 | 0.0% | 0.00% | – |
| Q1 2023 | $403,889 | -43.6% | 267,476 | -40.3% | 0.00% | – |
| Q4 2022 | $716,724 | +120.5% | 447,952 | +100.0% | 0.00% | – |
| Q3 2022 | $325,000 | -20.7% | 223,976 | 0.0% | 0.00% | – |
| Q2 2022 | $410,000 | -87.2% | 223,976 | -81.3% | 0.00% | – |
| Q1 2022 | $3,200,000 | -73.0% | 1,198,682 | -56.2% | 0.00% | -100.0% |
| Q4 2021 | $11,862,000 | -42.3% | 2,739,544 | -32.1% | 0.00% | 0.0% |
| Q3 2021 | $20,548,000 | -29.7% | 4,036,937 | -12.6% | 0.00% | -50.0% |
| Q2 2021 | $29,223,000 | +12.6% | 4,616,562 | +37.4% | 0.00% | +100.0% |
| Q1 2021 | $25,964,000 | +93.3% | 3,358,865 | +63.8% | 0.00% | 0.0% |
| Q4 2020 | $13,431,000 | -6.0% | 2,050,597 | -4.6% | 0.00% | 0.0% |
| Q3 2020 | $14,293,000 | -21.9% | 2,149,254 | -2.1% | 0.00% | 0.0% |
| Q2 2020 | $18,290,000 | +141.6% | 2,195,649 | +122.5% | 0.00% | 0.0% |
| Q1 2020 | $7,570,000 | -7.9% | 986,948 | -0.3% | 0.00% | 0.0% |
| Q4 2019 | $8,223,000 | -27.7% | 989,570 | -35.8% | 0.00% | 0.0% |
| Q3 2019 | $11,370,000 | -41.5% | 1,540,689 | -11.1% | 0.00% | 0.0% |
| Q2 2019 | $19,449,000 | -13.6% | 1,733,453 | -17.2% | 0.00% | -50.0% |
| Q1 2019 | $22,516,000 | -3.2% | 2,094,485 | +36.0% | 0.00% | 0.0% |
| Q4 2018 | $23,253,000 | -36.6% | 1,539,950 | -22.3% | 0.00% | -33.3% |
| Q3 2018 | $36,658,000 | -6.3% | 1,981,550 | +15.7% | 0.00% | 0.0% |
| Q2 2018 | $39,138,000 | +19.3% | 1,712,121 | +48.5% | 0.00% | 0.0% |
| Q1 2018 | $32,805,000 | +42.3% | 1,152,958 | +5.6% | 0.00% | +50.0% |
| Q4 2017 | $23,047,000 | +48.5% | 1,091,816 | +27.8% | 0.00% | +100.0% |
| Q3 2017 | $15,521,000 | +124.5% | 854,018 | +91.3% | 0.00% | 0.0% |
| Q2 2017 | $6,914,000 | +42.5% | 446,315 | +58.8% | 0.00% | – |
| Q1 2017 | $4,852,000 | +60.3% | 280,973 | +2.0% | 0.00% | – |
| Q4 2016 | $3,027,000 | -28.7% | 275,483 | +1.7% | 0.00% | – |
| Q3 2016 | $4,248,000 | +63.4% | 270,887 | +6.4% | 0.00% | – |
| Q2 2016 | $2,599,000 | +119.9% | 254,501 | +177.3% | 0.00% | – |
| Q1 2016 | $1,182,000 | -16.8% | 91,777 | +34.8% | 0.00% | – |
| Q4 2015 | $1,421,000 | – | 68,079 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |